Post by icemandios on Oct 14, 2020 12:49:02 GMT
Louis Stokes Cleveland VA Medical Center Purchases ViewRay's MRIdian Linac for MRI-Guided Radiation Therapy
MRIdian to Bring Benefits of MRI-Guided Radiation Therapy to Veterans Throughout Ohio and the Surrounding Region
CLEVELAND , Oct. 14, 2020 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today that the Louis Stokes Cleveland VA Medical Center in Cleveland, Ohio has purchased the MRIdian ® Linac MRI-Guided Therapy System, a cutting-edge radiation therapy device that combines the latest innovations in precision radiation delivery and ground-breaking MR-guidance.
MRIdian offers advantages for the delivery of safe and effective radiotherapy, including the ability to see the tumor and surrounding tissue during treatment, adapt the therapy in response to changes in patient anatomy and tumor size during treatment, continuous tracking of the tumor during treatment, and automatic pausing of the radiation if the tumor moves outside of the boundary. As a result, the system delivers ablative, high-dose radiation to the tumor while protecting the surrounding healthy tissue from damage.
The ability to deliver high-dose radiation treatments, referred to as stereotactic body radiation therapy (SBRT), means patients can receive their treatment in fewer sessions than conventional radiation therapy. Instead of 25 to 40 treatment sessions, patients receiving SBRT may complete treatment in as few as one to five treatment sessions. This is particularly beneficial for patients who may have to travel a long distance for treatment.
The Louis Stokes Cleveland VA Medical Center is part of the VA Northeast Ohio Healthcare System, which provides comprehensive, seamless health care and social services for 112,589 Veterans across Northeast Ohio . The VA Northeast Ohio Healthcare System focuses on treating the whole Veteran through health promotion and disease prevention. VA Northeast Ohio Healthcare System contributes to the future of medicine through education, training, and research programs.
"We're proud to support the Louis Stokes Cleveland VA Medical Center in their mission to offer the most advanced technologies to Veterans," said Paul Ziegler , Senior Vice President of Sales and Marketing at ViewRay. "Their investment in a MRIdian program furthers their commitment to delivering the highest quality health care to our nation's heroes."
Currently 39 MRIdian systems are installed at hospitals around the world, where they are used to treat a wide variety of solid tumors and are the focus of numerous ongoing research efforts. MRIdian has been the subject of hundreds of peer-reviewed publications, scientific meeting abstracts and presentations. More than 10,000 patients have been treated with MRIdian. For a list of treatment centers, please visit: viewray.com/find-mridian-mri-guided-radiation-therapy .
About ViewRay
ViewRay, Inc. (Nasdaq: VRAY), designs, manufactures and markets the MRIdian ® radiation therapy system. MRIdian is built upon a proprietary high-definition MR imaging system designed from the ground up to address the unique challenges and clinical workflow for advanced radiation oncology. Unlike MR systems used in diagnostic radiology, MRIdian's high-definition MR was purpose built to address specific challenges, including beam distortion, skin toxicity, and other concerns that potentially may arise when high magnetic fields interact with radiation beams. ViewRay and MRIdian are registered trademarks of ViewRay, Inc.